Positive 14-3-3 protein in cerebrospinal fluid followed by poppy-induced delayed post-hypoxic leukoencephalopathy: A case report. | Canada Hyperbarics Skip to main content
Case Study Heliyon 2024

Positive 14-3-3 protein in cerebrospinal fluid followed by poppy-induced delayed post-hypoxic leukoencephalopathy: A case report.

Shen G, Dong H, Zhao J, Wu S, Lee KY, Chi L — Heliyon, 2024

Tier 2, Indexed

Automatically imported from PubMed based on relevance criteria.

Summary

What Researchers Did

Researchers reported the case of a 70-year-old female who developed delayed post-hypoxic leukoencephalopathy (DPHL) after a poppy overdose, presenting with choreoathetosis, dementia, and positive 14-3-3 protein in cerebrospinal fluid.

What They Found

They found that a 70-year-old female developed progressive cognitive decline, apraxia, and choreic movements two weeks after a homemade refined opium poppy paste overdose. Brain magnetic resonance imaging showed characteristic bilateral symmetrical hyperintense signals, and 14-3-3 protein was detected in her cerebrospinal fluid, while other CSF analyses were negative.

What This Means for Canadian Patients

This case highlights that 14-3-3 protein in CSF could be a diagnostic marker for DPHL following poppy-induced hypoxia, even in the absence of other CSF abnormalities. Clinicians should consider DPHL in patients presenting with neurological deterioration after a lucid interval following opioid overdose.

Canadian Relevance

There is no specific Canadian connection identified for this case report.

Study Limitations

The primary limitation is that this is a single case report, which limits the generalizability of its findings to a broader patient population.

Was this summary helpful?

Study Details

Study Type Case Study
Category Carbon Monoxide Poisoning
Source Pubmed
PubMed ID 39296161
Year Published 2024
Journal Heliyon

Cite This Study

Share

Find a Canadian Clinic Treating Carbon Monoxide Poisoning

Browse verified hyperbaric facilities across Canada.

View Canadian Facilities

Disclaimer: This study summary is provided for informational and educational purposes only. It does not constitute medical advice. The information presented reflects the findings of the original research authors and may not represent the views of Canada Hyperbarics. Always consult a qualified healthcare professional before making treatment decisions.